Medtronic Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis
23 September 2021 - 12:55AM
Dow Jones News
By Robb M. Stewart
Medtronic PLC said Wednesday it has begun a pediatric clinical
trial of its spinal tether for the treatment of scoliosis.
The medical-technology company said it enrolled its first
patient and completed the first surgical procedure in its Braive
IDE study, which will evaluate the safety and effectiveness of the
growth modulation system for treatment of progressive adolescent
idiopathic scoliosis.
The first patient was recruited by the Newcastle Upon Tyne
Hospitals NHS Foundation Trust in England. The device is
Medtronic's latest in the pediatric spine category, and the study's
initiation reaffirms the company's commitment to continued
innovation for pediatric patients, it said.
In morning trading, Medtronics shares were up 1% at $129.09, for
a gain of 10% since the end of last year.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
September 22, 2021 10:40 ET (14:40 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2024 to May 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From May 2023 to May 2024